The FDA has awarded US approval to Pfenex’s drug PF708, it has emerged, as a treatment for osteoporosis in certain patients at high risk for fracture, just like its reference product, Eli Lilly’s Forteo (teriparatide...
Latest articles
Aethlon Medical gets US FDA nod to initiate early feasibility study of Hemopurifier in patients with head & neck cancer in combo Keytruda
Aethlon Medical, a therapeutic medical device and technology company focused on unmet needs in global health, announced that the US FDA has approved its Investigational Device Exemption (IDE) application to initiate an...
US FDA approves Galderma’s Aklief cream to treat acne
Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced, that the US Food and Drug Administration (FDA) approved Aklief (trifarotene) cream, 0.005% for the topical
Hoe introduceer je een contentkalender in je organisatie? [Q&A]
Met veel mensen tegelijkertijd aan je content(strategie) werken, dat kan onoverzichtelijk worden. Hoe introduceer je een contentkalender? En hoe krijg je je collega’s zo ver dat ze ermee gaan werken? In deze...
Boehringer Ingelheim’s phase III INBUILD trial of nintedanib in patients across a range of progressive fibrosing interstitial lung diseases meets primary endpoint
Boehringer Ingelheim, a research─driven pharmaceutical company, announced that in the phase III INBUILD trial nintedanib slowed lung function decline by 57% across the overall study population, as assessed
Diabetes drug could halt progression of multiple sclerosis, study suggests
Clinical trial in MS patients is planned following successful animal tests
